Publications

Export 47 results:
Sort by: Author [ Title (Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Hegazy MI. Assessment of pain in multiple sclerosis patients: Clinical, radiological and algometric study.. 2012. Abstract
n/a
C
Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny AN, Nemr AA, Hassan A, et al. characteristics and predictors of progression in an egyptian multiple sclerosis cohort: a multicenter registry study. Neuropsychiatric disease and treatment. 2017;13:1895. Abstract
n/a
El Sharkawi FZ, Ali SA, Hegazy MI, Atya HB. The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.. 2019;685:164-9. Abstract
n/a
El Sharkawi FZ, Ali SA HM. The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.. 2019;685. Abstract
n/a
El-Ghoneimy AT, Gad AH, Samir H, Shalaby NM, Ramzy GM, Farghaly M, et al. Contribution of vitamin D to the pathogenesis of multiple sclerosis and its effect on bone. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2009;49:209-22. Abstract
n/a
El-Ghoneimy AT, Gad AH, Samir H, Shalaby NM, Ramzy GM, Farghaly M, et al. Contribution of vitamin D to the pathogenesis of multiple sclerosis and its effect on bone. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2009;49:209-22. Abstract
n/a
El-Ghoneimy AT, Gad AH, Samir H, Shalaby NM, Ramzy GM, Farghaly M, et al. Contribution of vitamin D to the pathogenesis of multiple sclerosis and its effect on bone. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2009;49:209-22. Abstract
n/a
D
Hegazy M, El-ghoneimy A, Gad A, Samir H, Shalaby N, Ramzy G, et al. Does vitamin D deficiency play a role in cognitive dysfunction in patients with multiple sclerosis? European Journal of Neurology. 2009;16:277. Abstract
n/a
E
Gad A, Hegazy M, Hashem H, Hashem M. The effect of immunomodulator and immunosuppressant drugs on fatigue in multiple sclerosis. Egypt J Neurol Psychiat Neurosurg. 2014;51(4):439-44. Abstract
n/a
Gad A, Hegazy M, Hashem H, Hashem M. The effect of immunomodulator and immunosuppressant drugs on fatigue in multiple sclerosis. Egypt J Neurol Psychiat Neurosurg. 2014;51:439-44. Abstract
n/a
G
of Collaborators TG. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.. 2018;379(25). Abstract
n/a
Collaborators GB. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159):1684-735. Abstract
n/a
Collaborators GB. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159). Abstract
n/a
Collaborators GB. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159):1736-88. Abstract
n/a
of Collaborators GB. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017.. 2018;392(10159). Abstract
n/a
Collaborators GB. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2018;17(11):954-76. Abstract
n/a
Collaborators GB. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2019;18(5). Abstract
n/a
Collaborators GB. Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2018;17(11):939-53. Abstract
n/a
Collaborators GB. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2019;18(5). Abstract
n/a
and Collaborators GB. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.. 2018;18(1). Abstract
n/a
I
ElGhoneimy AT, Gad AH, Samir H, Shalaby NM, Ramzy GM, Farghaly M, et al. Impact of vitamin D deficiency on cognition in patients with multiple sclerosis. Egypt J Neurol Psychiatry Neurosurg. 2009;46:223-34. Abstract
n/a
ElGhoneimy AT, Gad AH, Samir H, Shalaby NM, Ramzy GM, Farghaly M, et al. Impact of vitamin D deficiency on cognition in patients with multiple sclerosis. Egypt J Neurol Psychiatry Neurosurg. 2009;46:223-34. Abstract
n/a
ElGhoneimy AT, Gad AH, Samir H, Shalaby NM, Ramzy GM, Farghaly M, et al. Impact of vitamin D deficiency on cognition in patients with multiple sclerosis. Egypt J Neurol Psychiatry Neurosurg. 2009;46:223-34. Abstract
n/a
Atya HB, Ali SA, Hegazy MI, El Sharkawi FZ. Is rs763780 in IL-17F gene considered risk factor to multiple sclerosis in Egyptian patients? Meta Gene. 2017;14:124-8. Abstract
n/a
K
Hamdy S, Shehata HS, Kishk N, Hassan A, Hegazy M, Shalaby N, et al. Kasr Al-Ainy Proposed Protocol for Diagnosis and Treatment of Multiple Sclerosis. I: Diagnosis. Egyptian Journal of Neurology, Psychiatry & Neurosurgery. 2015;52(1). Abstract
n/a